Patent · US Active

Factor VII polypeptides that are modified and uses thereof

US9476037B2 · kind B2 · utility

2Cited by

41References

30Claims

0Family size

Assignee

Catalyst Biosciences, Inc. · US

Inventors

Edwin L. Madison · Dallas, US
Christopher D. Thanos · Tiburon, US

Key dates

Filing date	Jul 30, 2013
Grant date	Oct 25, 2016
Priority date	—
Expiry date	Mar 18, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Modified factor VII polypeptides and uses thereof are provided. Such modified FVII polypeptides include Factor VIIa and other forms of Factor VII. Among modified FVII polypeptides provided are those that have altered activities, typically altered procoagulant activity, including increased procoagulant activities. Hence, such modified polypeptides are therapeutics.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.